Matthew E Korenberg
CIK 1649903 · CFO, Treasurer · last filed 2026-06-16
Matthew E Korenberg is a CFO, Treasurer who has filed 67 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing shows the insider exercised options covering $13.6K of PVLA on Jun 16, 2026. Across all open-market trades the lifetime net is −$12.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $15.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$15.39M
4
67
-$12.53M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PVLA | CFO, Treasurer | 1,000 | $157.77 | $157.8K | $0 | 4 | 2026-06-16 |
| LFCR | Director | 69,967 | $5.01 | $350.5K | $0 | 3 | 2026-06-05 |
| LGND | President & COO | 50,777 | $293.15 | $14.89M | -$12.53M | 50 | 2024-09-24 |
| Qualigen Therapeutics, Inc. (QLGN) Delisted | Director | — | $3.21 | — | $0 | 2 | 2022-08-04 |
Recent Filings
67 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-16 | PVLA | Exer (M) | +1,000 | $13.6K | EDGAR |
| 2026-06-05 | LFCR | Grant (A) | +25,907 | $0 | EDGAR |
| 2026-02-09 | PVLA | Grant (A) | — | $0 | EDGAR |
| 2025-07-17 | LFCR | Grant (A) | +19,506 | $0 | EDGAR |
| 2025-02-10 | PVLA | Grant (A) | — | $0 | EDGAR |
| 2024-12-17 | PVLA | Grant (A) | — | $0 | EDGAR |
| 2024-11-12 | LGND | Notice (144) | −32,183 | -$3.87M | EDGAR |
| 2024-09-24 | LGND | Mixed | −1,293 | -$878.1K | EDGAR |
| 2024-09-23 | LGND | Notice (144) | −14,437 | -$1.47M | EDGAR |
| 2024-09-20 | LGND | Notice (144) | −6,275 | -$653.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.